Compound Safety Prediction,
Pfizer Global Research and Development,
Dr. Sashi Nadanaciva is an Senior Manager for Pfizer Oncology, USA. He received a Doctoral Degree (PhD) in Enzymology from University of Oxford, England. He is a graduated in Biochemistry from University of Oxford, England, with an immediate post-graduation from Temple University, USA in 2014. He served as Scientist for 6 years in Pfizer, USA. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of research. His research interests lie in Oncology. His area of expertise credits him with many publications in national and international journals.
Proteomics, Cancer Research, Microbiology, Clinical Trials, Clinical Oncology, Clinical Proteomics